Eye Center, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Eur J Ophthalmol. 2021 May;31(3):994-1001. doi: 10.1177/1120672120930607. Epub 2020 May 29.
To compare the efficacy of small incision lenticule extraction (SMILE) and toric implantable collamer lens (TICL) implantation for myopic astigmatism correction using vector analysis.
In this retrospective study, 171 eyes of 171 patients with cylinder ⩾1.0 diopters (D) were recruited, with 97 eyes underwent SMILE and 74 eyes underwent TICL implantation. Preoperative and 3-months postoperative visual and refractive results were examined. The astigmatism correction, graded by the degree of preoperative cylinder was compared between two groups using vector analysis.
At 3-months postoperatively, the residual cylinder was -0.10 ± 0.21 D in the SMILE group and -0.30 ± 0.32 D in the TCL group ( < 0.05). Furthermore, 98% and 85% of eyes had the cylinder within ±0.5 D in the SMILE and TICL group, respectively. The vector analysis revealed similar target induced astigmatism vector in two groups. However, the difference vector, magnitude of error, angle of error, and index of success were significantly higher (0.30 ± 0.32 D, -0.19 ± 0.25, -2° ± 4.35°, and 0.16 ± 0.17 D, respectively) in the TICL group than the values in the SMILE group (0.10 ± 0.21 D, -0.05 ± 0.20, -0.03° ± 2.13°, and 0.05 ± 0.12, respectively), regardless of the degree of preoperative cylinder (all < 0.05). For preoperative cylinder < 2.0 D, surgically induced astigmatism vector and correction index in the SMILE group were higher than those in the TICL group ( < 0.05).
Both SMILE and TICL implantation are effective techniques for myopic astigmatism correction. However, the accuracy of correction in the magnitude and axis of astigmatism with SMILE was better than that achieved with TICL implantation.
通过向量分析比较小切口微透镜提取术(SMILE)和可植入性角膜胶原透镜(TICL)植入术治疗近视散光的疗效。
本回顾性研究纳入了 171 例(171 只眼)球镜 ⩾1.0 屈光度(D)的患者,其中 97 只眼行 SMILE 手术,74 只眼行 TICL 植入术。术前和术后 3 个月评估视力和屈光结果。通过向量分析比较两组不同术前散光程度的散光矫正情况。
术后 3 个月时,SMILE 组的残余散光为 -0.10±0.21 D,TICL 组为 -0.30±0.32 D( < 0.05)。此外,SMILE 组和 TICL 组分别有 98%和 85%的眼散光在±0.5 D 以内。向量分析显示两组的目标诱导散光向量相似。然而,TICL 组的差异向量、误差幅度、误差角度和成功率指数明显更高(0.30±0.32 D、-0.19±0.25、-2°±4.35°和 0.16±0.17 D),SMILE 组分别为(0.10±0.21 D、-0.05±0.20、-0.03°±2.13°和 0.05±0.12 D),无论术前散光程度如何(均 < 0.05)。对于术前散光<2.0 D 的患者,SMILE 组的手术诱导散光向量和矫正指数均高于 TICL 组( < 0.05)。
SMILE 和 TICL 植入术都是治疗近视散光的有效方法。然而,SMILE 在散光的大小和轴向上的矫正准确性优于 TICL 植入术。